Author Question: A client with myasthenia gravis is prescribed pyridostigmine bromide (Mestinon) to: a. decrease ... (Read 61 times)

Kthamas · **on:** Jul 24, 2018

A client with myasthenia gravis is prescribed pyridostigmine bromide (Mestinon) to:

a. decrease concentration of dopamine.
b. increase concentration of acetylcholine.
c. decrease activity at the internuncial neurons.
d. increase calcium use in the skeletal muscles.

Question 2

A 40-year-old woman is prescribed dantrolene. The nurse should monitor the client for:

a. gastrointestinal upset. c. hepatotoxicity.
b. increased risk of urinary tract infection. d. nephrotoxicity.

lkoler · **Reply #1 on:** Jul 24, 2018

Answer to Question 1

ANS: B

Feedback
A Incorrect: This is not an action of a skeletal muscle stimulant.
B Correct: Mestinon inhibits cholinesterase to increase concentration of acetylcholine.
C Incorrect: Mestinon does not have this action. This describes a centrally acting skeletal muscle relaxant.
D Incorrect: This is not the action of mestinon.

Answer to Question 2

ANS: C

Feedback
A Incorrect: Although a possible adverse effect, this is not the best answer.
B Incorrect: UTIs are not associated with dantrolene.
C Correct: Women clients over 35 years of age are at risk for hepatotoxicity when using dantrolene.
D Incorrect: This is not associated with dantrolene.